Predictive Oncology Secures Massive $343.5M for Strategic Aethir Investment
In a significant move shaking the digital asset landscape, Nasdaq-listed Predictive Oncology (POAI) has successfully completed a substantial private investment in public equity (PIPE) offering. This pivotal development earmarks a massive $343.5 million to bolster its strategic Aethir investment. The announcement has captured widespread attention, especially among those keenly observing the convergence of traditional finance […]
